| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2015 | A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients | Chuang M.-K.; Chiu Y.-C.; WEN-CHIEN CHOU ; Hou H.-A.; Chuang E.Y.; Tien H.-F. | Leukemia | 38 | 41 | |
| 2020 | A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients | Wang Y.-H.; Lin C.-C.; Yao C.-Y.; Hsu C.-L.; Hou H.-A.; Tsai C.-H.; WEN-CHIEN CHOU ; Tien H.-F. | Blood Advances | 7 | 7 | |
| 2017 | A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes | Yao C.-Y.; Chen C.-H.; Huang H.-H.; Hou H.-A.; Lin C.-C.; Tseng M.-H.; Kao C.-J.; Lu T.-P.; WEN-CHIEN CHOU ; Tien H.-F. | Blood Advances | 11 | ||
| 1998 | Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia | Huang S.-Y.I.; Chang C.-S.; Tang J.-L.; Tien H.-F.; Kuo T.-L.I.; Huang S.-F.; Yao Y.U.-T.; WEN-CHIEN CHOU ; Chung C.-Y.; Wang C.-H.; Shen M.-C.; Chen Y.-C. | British Journal of Haematology | 98 | 99 | |
| 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | WEN-CHIEN CHOU ; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. | Leukemia | 43 | 45 | |
| 2005 | Acute promyelocytic leukemia: Recent advances in therapy and molecular basis of response to arsenic therapies | WEN-CHIEN CHOU ; Dang C.V. | Current Opinion in Hematology | 68 | 61 | |
| 2019 | Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study | Liu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; WEN-CHIEN CHOU ; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. | British Journal of Haematology | 2 | 4 | |
| 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | Tang J.-L.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F. | Blood | 230 | 236 | |
| 2001 | Arsenic inhibition of telomerase transcription leads to genetic instability | WEN-CHIEN CHOU ; Hawkins A.L.; Barrett J.F.; Griffin C.A.; Dang C.V. | Journal of Clinical Investigation | 106 | 103 | |
| 2005 | Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation | WEN-CHIEN CHOU ; Chen H.-Y.; Yu S.-L.; Cheng L.; Yang P.-C.; Dang C.V. | Blood | 65 | 60 | |
| 2020 | ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden | Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; WEN-CHIEN CHOU ; Tang J.-L.; Tien H.-F. | Blood Cancer Journal | 2 | 2 | |
| 2017 | Aurora A and NF-κB survival pathway drive chemoresistance in acute myeloid leukemia via the TRAF-interacting protein TIFA | Wei T.-Y.W.; Wu P.-Y.; Wu T.-J.; Hou H.-A.; WEN-CHIEN CHOU ; Teng C.-L.J.; Lin C.-R.; Chen J.-M.M.; Lin T.-Y.; Su H.-C.; Huang C.-C.F.; Yu C.-T.R.; Hsu S.-L.; Tien H.-F.; Tsai M.-D. | Cancer Research | 23 | 27 | |
| 2009 | Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival | Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; WEN-CHIEN CHOU ; Hsu S.-C.; Tsay W.; Yu C.-W.; Hsu C.-Y.; Tien H.-F.; Yang P.-C. | Blood | 63 | 58 | |
| 2022 | Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients | Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO; Tang, Jih-Luh; Wu, Shang-Ju; WEN-CHIEN CHOU ; SZU-CHUN HSU; Ko, Bor-Sheng; Tien, Hwei-Fang | Journal of the Formosan Medical Association = Taiwan yi zhi | 0 | ||
| 2014 | Calreticulin mutation was rarely detected in patients with myelodysplastic syndrome | Hou H.-A.; Kuo Y.-Y.; WEN-CHIEN CHOU ; Chen P.-H.; Tien H.-F. | Leukemia | 7 | 7 | |
| 2011 | CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia | Lin T.-C.; Hou H.-A.; WEN-CHIEN CHOU ; Ou D.-L.; Yu S.-L.; Tien H.-F.; Lin L.-I. | Leukemia | 36 | ||
| 2010 | Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia | Hou H.-A.; Shih T.T.F.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Yao M.; Huang S.-Y.; WEN-CHIEN CHOU ; Hsu C.-Y.; Tien H.-F. | Haematologica | 13 | 14 | |
| 2016 | Characteristics of Taiwanese patients of PNH in the international PNH registry | WEN-CHIEN CHOU ; Huang W.-H.; Wang M.-C.; Chang C.-S.; Yeh S.-P.; Chiou T.-J.; Chen Y.-C.; Lin T.-H.; Shen M.-C.; on behalf of the Taiwan PNH study group | Thrombosis Journal | 0 | ||
| 2008 | Characterization of acute myeloid leukemia with PTPN11 mutation: The mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD | Hou H.-A.; WEN-CHIEN CHOU ; Lin L.-I.; Chen C.-Y.; Tang J.-L.; Tseng M.-H.; Huang C.-F.; Chiou R.-J.; Lee F.-Y.; Liu M.-C.; Tien H.-F. | Leukemia | 45 | 49 | |
| 2013 | Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence - Clinical implication and comparison between the West and the East | Wu S.-J.; Lin C.-T.; Huang S.-Y.; Lee F.-Y.; Liu M.-C.; Hou H.-A.; Chen C.-Y.; Ko B.-S.; WEN-CHIEN CHOU ; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F. | Annals of Hematology | 11 | 9 |
